Journal
SCIENCE ADVANCES
Volume 6, Issue 41, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aat5979
Keywords
-
Categories
Funding
- Inserm
- European Union [602102, 2IONXXID/REID/ID17HRU208, ANR-14-CE13-0018-03]
- Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony in Germany
- Polish Ministry of Science and Higher Education [888/N-ESF-EuroEPINOMICS/10/2011/0, W19/7, PR/2014]
- NIH [GM123558]
- Agence Nationale de la Recherche (ANR) [ANR-14-CE13-0018] Funding Source: Agence Nationale de la Recherche (ANR)
Ask authors/readers for more resources
Gene and protein expressions display circadian oscillations, which can be disrupted in diseases in most body organs. Whether these oscillations occur in the healthy hippocampus and whether they are altered in epilepsy are not known. We identified more than 1200 daily oscillating transcripts in the hippocampus of control mice and 1600 in experimental epilepsy, with only one-fourth oscillating in both conditions. Comparison of gene oscillations in control and epilepsy predicted time-dependent alterations in energy metabolism, which were verified experimentally. Although aerobic glycolysis remained constant from morning to afternoon in controls, it increased in epilepsy. In contrast, oxidative phosphorylation increased in control and decreased in epilepsy. Thus, the control hippocampus shows circadian molecular remapping, which is altered in epilepsy. We suggest that the hippocampus operates in a different functioning mode in epilepsy. These alterations need to be considered when studying epilepsy mechanisms, designing drug treatments, and timing their delivery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available